Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricarda Evens

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Biomed Research International|April 17, 2014
Fear processing in dental phobia during crossmodal symptom provocation: an fMRI studyKevin Hilbert, Ricarda Evens, Nina Isabel Maslowski, et al.
Npj Mental Health Research|July 9, 2026
Personality changes following first-time psychedelic use in college students in GermanyConstantin Volkmann, Michael Seitz, Ricarda Evens, et al.
Psychological Medicine|April 1, 2026
Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey studyRicarda Evens, Abdo Uyar, Emily Gosslau, et al.
Frontiers in Psychiatry|March 11, 2020
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes AcceptanceMax Wolff, Ricarda Evens, Lea J Mertens, et al.
Journal of Psychopharmacology (Oxford, England)|April 1, 2025
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsTomislav Majić, Timo Torsten Schmidt, Anna Gröticke, et al.
Neuropsychologia|May 16, 2015
The impact of Parkinson's disease and subthalamic deep brain stimulation on reward processingRicarda Evens, Yuliya Stankevich, Maja Dshemuchadse, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2024
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)Max Wolff, Ricarda Evens, Lea J Mertens, et al.
Neurobiology of Aging|February 2, 2016
Dopamine modulation of spatial navigation memory in Parkinson's diseaseFranka Thurm, Nicolas W Schuck, Mareike Fauser, et al.
Neuroscience Applied|July 14, 2025
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study designLea J Mertens, Michael Koslowski, Felix Betzler, et al.
Frontiers in Psychiatry|November 22, 2021
Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online SurveyRicarda Evens, Simon Reiche, Roman M Marek, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Biomed Research International|April 17, 2014
Fear processing in dental phobia during crossmodal symptom provocation: an fMRI studyKevin Hilbert, Ricarda Evens, Nina Isabel Maslowski, et al.
Npj Mental Health Research|July 9, 2026
Personality changes following first-time psychedelic use in college students in GermanyConstantin Volkmann, Michael Seitz, Ricarda Evens, et al.
Psychological Medicine|April 1, 2026
Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey studyRicarda Evens, Abdo Uyar, Emily Gosslau, et al.
Frontiers in Psychiatry|March 11, 2020
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes AcceptanceMax Wolff, Ricarda Evens, Lea J Mertens, et al.
Journal of Psychopharmacology (Oxford, England)|April 1, 2025
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsTomislav Majić, Timo Torsten Schmidt, Anna Gröticke, et al.
Neuropsychologia|May 16, 2015
The impact of Parkinson's disease and subthalamic deep brain stimulation on reward processingRicarda Evens, Yuliya Stankevich, Maja Dshemuchadse, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2024
Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)Max Wolff, Ricarda Evens, Lea J Mertens, et al.
Neurobiology of Aging|February 2, 2016
Dopamine modulation of spatial navigation memory in Parkinson's diseaseFranka Thurm, Nicolas W Schuck, Mareike Fauser, et al.
Neuroscience Applied|July 14, 2025
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study designLea J Mertens, Michael Koslowski, Felix Betzler, et al.
Frontiers in Psychiatry|November 22, 2021
Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online SurveyRicarda Evens, Simon Reiche, Roman M Marek, et al.
Pageof 3